Correlates of pain in an in-treatment sample of opioid-dependent people

Authors


  • Suzanne Nielsen, BPharm, PhD, NHMRC Research Fellow (Early Career), Briony Larance, BSc (Psych), (Hons) PhD, Senior Research Officer, Nicholas Lintzeris, BMedSci, MBBS, PhD, FAChAM, Clinical Associate Professor and Director, Emma Black, BSc(Hons), Senior Research Officer, Raimondo Bruno, PhD, Senior Lecturer, Bridin Murnion, MBChB, FRACP, FFPMANZCA, FAChAM, Clinical Senior Lecturer, Adrian Dunlop, MBBS, PhD, FAChAM, Clinical Associate Professor and Director, Louisa Degenhardt, PhD, Professor.

Correspondence to Dr Suzanne Nielsen, Addiction Medicine, Drug Health Services, Central Clinical School C39—Royal Prince Alfred Hospital, The University of Sydney, NSW 2006, Australia. Tel: +61 2 9515 9092; Fax: +61 2 9332 8700; E-mail: Suzanne.nielsen@sydney.edu.au

Abstract

Introduction and Aims

The limited literature on pain in opioid-treatment samples indicates that it is highly prevalent. Understanding the implications of pain on treatment outcomes is important, particularly in light of ageing opioid-treatment cohorts. This study explores correlates of pain, including aberrant behaviours related to prescribed opioids. Our hypothesis is that pain may increase aberrant opioid-related behaviours, including illicit substance use, among opioid-dependent people.

Design and Methods

We examined pain in methadone or buprenorphine patients (n = 141) from three treatment services. Measures included basic demographics, Brief Pain Inventory, general mental health, physical health and quality of life measures, pain history and treatments, and an aberrant opioid-related behaviour scale. Univariate and multivariate analyses were used to examine correlates of pain.

Results

Forty percent reported current pain, measured with the first question of the Brief Pain Inventory. Correlates of pain were depression ratings [adjusted odds ratio (OR) 2.24, 95% confidence interval (CI) 1.04, 4.83], anxiety ratings (adjusted OR 4.29, 95% CI 1.88, 9.80) and self-reported health ratings (adjusted OR 0.35, 95% CI 0.16, 0.76). Contrary to our hypothesis, pain was not associated with greater use of illicit opioids, nor any aberrant opioid-related behaviours. Pain was comparable among methadone and buprenorphine patients.

Discussion and Conclusions

The lack of association with pain and aberrant behaviours suggest that it should not be assumed that those in opioid treatment misuse medications in response to pain. The high prevalence of depression/anxiety symptoms indicates a need for further work with larger samples to explore pain and co-morbidity among opioid-dependent people. [Nielsen S, Larance B, Lintzeris N, Black E, Bruno R, Murnion B, Dunlop A, Degenhardt L. Correlates of pain in an in-treatment sample of opioid-dependent people. Drug Alcohol Rev 2013;32:489–494]

Ancillary